BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 75 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $13,163,000 | +52.6% | 2,079,497 | +6.3% | 0.00% | +100.0% |
| Q3 2016 | $8,628,000 | +63.9% | 1,956,570 | +5.5% | 0.00% | 0.0% |
| Q2 2016 | $5,265,000 | -0.4% | 1,854,035 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $5,287,000 | -71.6% | 1,868,245 | +3.5% | 0.00% | -66.7% |
| Q4 2015 | $18,631,000 | -3.4% | 1,805,315 | +6.7% | 0.00% | 0.0% |
| Q3 2015 | $19,292,000 | -29.2% | 1,692,262 | -7.2% | 0.00% | -25.0% |
| Q2 2015 | $27,232,000 | +57.6% | 1,823,953 | -4.7% | 0.00% | +33.3% |
| Q1 2015 | $17,277,000 | -25.7% | 1,913,277 | +0.0% | 0.00% | -25.0% |
| Q4 2014 | $23,260,000 | +23.1% | 1,912,804 | -1.0% | 0.00% | +33.3% |
| Q3 2014 | $18,899,000 | -23.8% | 1,932,365 | -0.6% | 0.00% | -25.0% |
| Q2 2014 | $24,797,000 | +117.1% | 1,944,841 | +80.2% | 0.00% | +100.0% |
| Q1 2014 | $11,420,000 | +32.8% | 1,079,396 | -4.6% | 0.00% | 0.0% |
| Q4 2013 | $8,601,000 | +1.4% | 1,131,652 | -2.9% | 0.00% | 0.0% |
| Q3 2013 | $8,483,000 | +373.9% | 1,165,193 | +0.9% | 0.00% | – |
| Q2 2013 | $1,790,000 | – | 1,154,701 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $38,430,000 | 18.43% |
| RTW INVESTMENTS, LP | 4,078,895 | $25,819,000 | 9.72% |
| VHCP Management, LLC | 1,155,104 | $7,312,000 | 7.86% |
| RA Capital Management | 2,989,795 | $18,925,000 | 2.68% |
| DLD Asset Management, LP | 1,258,700 | $7,967,000 | 2.61% |
| Avoro Capital Advisors LLC | 1,631,502 | $10,327,000 | 2.09% |
| Ghost Tree Capital, LLC | 1,150,000 | $7,280,000 | 1.75% |
| GREAT POINT PARTNERS LLC | 725,000 | $4,589,000 | 0.94% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,237,734 | $20,495,000 | 0.84% |
| Baker Brothers Advisors | 10,963,944 | $69,402,000 | 0.68% |